je.st
news
Tag: cancer
Story of man's cancer ordeal opens doors to federally funded treatment
2013-10-16 06:46:51| Biotech - Topix.net
The story of a Brighton Township man's cancer battle has opened the door to federally funded treatment for him -- and potentially hundreds of other cancer patients -- despite the ongoing government shutdown.
Tags: story
treatment
cancer
opens
New Breast Cancer Gene Test Gives Patients More Options
2013-10-15 19:32:39| Biotech - Topix.net
A new test has been introduced to screen for inherited forms of breast cancer, offering patients an alternative to the test developed by Myriad Genetics, which was long the sole option available.
Tags: options
test
cancer
patients
Beer can goes pink for cancer awareness
2013-10-15 16:08:06| Industrial Machines - Topix.net
During Breast Cancer Awareness Month each October, organizations across the country work together to raise awareness about a disease that affects millions of women around the world.
Tags: pink
cancer
awareness
beer
Results of Phase II PRECEDENT Trial for Investigational Folate Receptor Therapy Vintafolide in Patients with Platinum-Resistant Ovarian Cancer Published in Journal of Clinical Oncology
2013-10-14 23:02:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION N.J., & WEST LAFAYETTE, Ind. Merck and Endocytes Phase III PROCEED pivotal trial of vintafolide in ovarian cancer ongoing WHITEHOUSE STATION N.J., & WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, (NYSE: MRK) and Endocyte, Inc. (NASDAQ: ECYT) today announced the online publication of results from the randomized Phase II PRECEDENT trial for vintafolide (MK-8109/EC145), an investigational folate small molecule drug conjugate (SMDC), in the Journal of Clinical Oncology (JCO), the official journal of the American Society of Clinical Oncology. Language: English Contact: MerckMedia:Caroline Lappetito,267-305-7639Caroline.Lappetito@Merck.comorClaire Mulhearn, 908-423-7425Claire.Mulhearn@Merck.comorInvestors:Carol Ferguson, 908-423-4465Carol.Ferguson@Merck.comorJustin Holko, 908-423-5088Justin_Holko@Merck.comorEndocyteMedia:Tony Russo, 212-845-4251Tony.Russo@Russopartnersllc.comorMartina Schwarzkopf, 212-845-4292Martina.Schwarzkopf@Russopartnersllc.comorInvestors:Stephanie Ascher, 212-362-1200Stephanie@sternir.com Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: ECYT Exchange: NASDAQ read more
Tags: of
results
journal
published
Family Urges Drug Companies to Give Father Access to Cancer Drug
2013-10-13 01:04:27| Biotech - Topix.net
Time is running out for a dying Denver father who is pleading with drug companies for access to a breakthrough cancer drug that could save him.
Tags: family
give
access
companies
Sites : [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] next »